Results Snapshot
Figures in Rs cr
Standalone Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2024 is -2.30% vs 34.37% in Sep 2023
Standalone Net Profit
Growth in half year ended Sep 2024 is -4.06% vs 48.35% in Sep 2023
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2024 is -14.06% vs 29.69% in Sep 2023
Interest
Growth in half year ended Sep 2024 is 181.82% vs -35.29% in Sep 2023
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2024 has fallen from Sep 2023
Compare Half Yearly Results Of Anuh Pharma With
Figures in Rs cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
303.86
4,933.00
-4,629.14
-93.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
303.86
4,933.00
-4,629.14
-93.84%
Raw Material Cost
206.71
386.36
-179.65
-46.50%
Purchase of Finished goods
13.07
988.27
-975.20
-98.68%
(Increase) / Decrease In Stocks
10.65
15.23
-4.58
-30.07%
Employee Cost
10.66
1,047.96
-1,037.30
-98.98%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
35.33
1,170.95
-1,135.62
-96.98%
Total Expenditure (Excl Depreciation)
276.42
3,608.77
-3,332.35
-92.34%
Operating Profit (PBDIT) excl Other Income
27.44
1,324.23
-1,296.79
-97.93%
Other Income
7.12
200.59
-193.47
-96.45%
Operating Profit (PBDIT)
34.56
1,524.82
-1,490.26
-97.73%
Interest
0.31
8.18
-7.87
-96.21%
Exceptional Items
0.00
61.23
-61.23
-100.00%
Gross Profit (PBDT)
34.25
1,516.64
-1,482.39
-97.74%
Depreciation
3.80
168.82
-165.02
-97.75%
Profit Before Tax
30.46
1,347.82
-1,317.36
-97.74%
Tax
5.91
261.13
-255.22
-97.74%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
24.55
1,086.69
-1,062.14
-97.74%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
24.55
1,147.92
-1,123.37
-97.86%
Equity Capital
25.06
40.06
-15.00
-37.44%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.90
28.66
-23.76
-82.90%
Diluted Earnings per share
4.90
28.61
-23.71
-82.87%
Operating Profit Margin (Excl OI)
9.03%
26.84%
0.00
-17.81%
Gross Profit Margin
11.27%
30.74%
0.00
-19.47%
PAT Margin
8.08%
22.03%
0.00
-13.95%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 303.86 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is -2.30% vs 34.37% in Sep 2023
Half Yearly - Standalone Net Profit
Standalone Net Profit 24.55 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is -4.06% vs 48.35% in Sep 2023
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 27.44 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is -14.06% vs 29.69% in Sep 2023
Half Yearly - Interest
Interest 0.31 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 181.82% vs -35.29% in Sep 2023
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.03%
in Sep 2024Figures in Rs %
Growth in half year ended Sep 2024 has fallen from Sep 2023